{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T12:05:39Z","timestamp":1784030739451,"version":"3.55.0"},"reference-count":29,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100005205","name":"Janssen Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Clin Pract"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1111\/ijcp.12807","type":"journal-article","created":{"date-parts":[[2016,5,30]],"date-time":"2016-05-30T05:03:28Z","timestamp":1464584608000},"page":"493-505","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Efficacy and safety of fulranumab as monotherapy in patients with moderate to severe, chronic knee pain of primary osteoarthritis: a randomised, placebo- and active-controlled trial"],"prefix":"10.1155","volume":"70","author":[{"given":"A. J.","family":"Mayorga","sequence":"first","affiliation":[{"name":"Janssen Research & Development, LLC; Titusville NJ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Wang","sequence":"additional","affiliation":[{"name":"Janssen Research & Development, LLC; Titusville NJ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. M.","family":"Kelly","sequence":"additional","affiliation":[{"name":"Janssen Research & Development, LLC; Titusville NJ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Thipphawong","sequence":"additional","affiliation":[{"name":"Janssen Research & Development, LLC; Fremont CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,5,30]]},"reference":[{"key":"10.1111\/ijcp.12807-BIB0001|ijcp12807-cit-0001","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P","article-title":"Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines","volume":"43","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1111\/ijcp.12807-BIB0002|ijcp12807-cit-0002","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.joca.2010.01.013","article-title":"OARSI recommendations for the management of hip and knee osteoarthritis","volume":"18","author":"Zhang","year":"2010","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1111\/ijcp.12807-BIB0003|ijcp12807-cit-0003","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1136\/bmj.38273.626655.63","article-title":"Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trials","volume":"329","author":"Bjordal","year":"2004","journal-title":"BMJ"},{"key":"10.1111\/ijcp.12807-BIB0004|ijcp12807-cit-0004","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2012.11.011","article-title":"Opioids for chronic pain: new evidence, new strategies, safe prescribing","volume":"126","author":"Leon-Casasola","year":"2013","journal-title":"Am J Med"},{"key":"10.1111\/ijcp.12807-BIB0005|ijcp12807-cit-0005","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1001\/archinte.165.9.978","article-title":"Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study","volume":"165","author":"Johnsen","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1111\/ijcp.12807-BIB0006|ijcp12807-cit-0006","first-page":"CD003115","article-title":"Oral or transdermal opioids for osteoarthritis of the knee or hip","author":"Nuesch","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/ijcp.12807-BIB0007|ijcp12807-cit-0007","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00045391-200007020-00004","article-title":"Renal and related cardiovascular effects of conventional and COX-2-specific NSAIDs and non-NSAID analgesics","volume":"7","author":"Whelton","year":"2000","journal-title":"Am J Ther"},{"key":"10.1111\/ijcp.12807-BIB0008|ijcp12807-cit-0008","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1023\/A:1022475432077","article-title":"Elevated nerve growth factor levels in the synovial fluid of patients with inflammatory joint disease","volume":"23","author":"Halliday","year":"1998","journal-title":"Neurochem Res"},{"key":"10.1111\/ijcp.12807-BIB0009|ijcp12807-cit-0009","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.tips.2005.12.001","article-title":"Novel class of pain drugs based on antagonism of NGF","volume":"27","author":"Hefti","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"10.1111\/ijcp.12807-BIB0010|ijcp12807-cit-0010","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0090-4295(01)01597-7","article-title":"Nerve growth factor and chronic prostatitis\/chronic pelvic pain syndrome","volume":"59","author":"Miller","year":"2002","journal-title":"Urology"},{"key":"10.1111\/ijcp.12807-BIB0011|ijcp12807-cit-0011","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1212\/WNL.57.1.132","article-title":"Levels of nerve growth factor in cerebrospinal fluid of chronic daily headache patients","volume":"57","author":"Sarchielli","year":"2001","journal-title":"Neurology"},{"key":"10.1111\/ijcp.12807-BIB0012|ijcp12807-cit-0012","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.joca.2013.06.004","article-title":"Nerve growth factor: an update on the science and therapy","volume":"21","author":"Seidel","year":"2013","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1111\/ijcp.12807-BIB0013|ijcp12807-cit-0013","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1523\/JNEUROSCI.13-05-02136.1993","article-title":"Nerve growth factor-induced hyperalgesia in the neonatal and adult rat","volume":"13","author":"Lewin","year":"1993","journal-title":"J Neurosci"},{"key":"10.1111\/ijcp.12807-BIB0014|ijcp12807-cit-0014","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/ana.410360221","article-title":"The effect of systemically administered recombinant human nerve growth factor in healthy human subjects","volume":"36","author":"Petty","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1111\/ijcp.12807-BIB0015|ijcp12807-cit-0015","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/nrd1107","article-title":"Neurotrophic factors as novel therapeutics for neuropathic pain","volume":"2","author":"Sah","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1111\/ijcp.12807-BIB0016|ijcp12807-cit-0016","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jpain.2004.02.538","article-title":"Effect of blockade of nerve growth factor and tumor necrosis factor on pain behaviors after plantar incision","volume":"5","author":"Zahn","year":"2004","journal-title":"J Pain"},{"key":"10.1111\/ijcp.12807-BIB0017|ijcp12807-cit-0017","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1016\/j.pain.2011.05.003","article-title":"Efficacy and safety of tanezumab in the treatment of chronic low back pain","volume":"152","author":"Katz","year":"2011","journal-title":"Pain"},{"key":"10.1111\/ijcp.12807-BIB0018|ijcp12807-cit-0018","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa0901510","article-title":"Tanezumab for the treatment of pain from osteoarthritis of the knee","volume":"363","author":"Lane","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1111\/ijcp.12807-BIB0019|ijcp12807-cit-0019","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1016\/j.pain.2013.05.051","article-title":"Efficacy, safety, and tolerability of fulranumab, an anti-nerve growth factor antibody, in the treatment of patients with moderate to severe osteoarthritis pain","volume":"154","author":"Sanga","year":"2013","journal-title":"Pain"},{"key":"10.1111\/ijcp.12807-BIB0020|ijcp12807-cit-0020","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/art.1780290816","article-title":"Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association","volume":"29","author":"Altman","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1111\/ijcp.12807-BIB0021|ijcp12807-cit-0021","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/ard.37.4.378","article-title":"Studies with pain rating scales","volume":"37","author":"Downie","year":"1978","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/ijcp.12807-BIB0022|ijcp12807-cit-0022","first-page":"S148","article-title":"The WOMAC Knee and Hip Osteoarthritis Indices: development, validation, globalization and influence on the development of the AUSCAN Hand Osteoarthritis Indices","volume":"23","author":"Bellamy","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1111\/ijcp.12807-BIB0023|ijcp12807-cit-0023","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/1529-0131(200110)45:5<453::AID-ART365>3.0.CO;2-W","article-title":"The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC): a review of its utility and measurement properties","volume":"45","author":"McConnell","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1111\/ijcp.12807-BIB0024|ijcp12807-cit-0024","first-page":"2635","article-title":"Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis","volume":"27","author":"Ehrich","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1111\/ijcp.12807-BIB0025|ijcp12807-cit-0025","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/1529-0131(200010)13:5<280::AID-ANR6>3.0.CO;2-6","article-title":"Comparison of the responsiveness of symptomatic outcome measures in knee osteoarthritis","volume":"13","author":"Gentelle-Bonnassies","year":"2000","journal-title":"Arthritis Care Res"},{"key":"10.1111\/ijcp.12807-BIB0026|ijcp12807-cit-0026","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1089\/acm.2008.0305","article-title":"Effects of noninvasive interactive neurostimulation on symptoms of osteoarthritis of the knee: a randomized, sham-controlled pilot study","volume":"14","author":"Selfe","year":"2008","journal-title":"J Altern Complement Med"},{"key":"10.1111\/ijcp.12807-BIB0027|ijcp12807-cit-0027","doi-asserted-by":"crossref","first-page":"c3515","DOI":"10.1136\/bmj.c3515","article-title":"Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study","volume":"341","author":"Nuesch","year":"2010","journal-title":"BMJ"},{"key":"10.1111\/ijcp.12807-BIB0028|ijcp12807-cit-0028","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1212\/01.wnl.0000275528.01263.6c","article-title":"Clinical trial outcome in neuropathic pain: relationship to study characteristics","volume":"70","author":"Katz","year":"2008","journal-title":"Neurology"},{"key":"10.1111\/ijcp.12807-BIB0029|ijcp12807-cit-0029","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1212\/WNL.65.12_suppl_4.S32","article-title":"Methodological issues in clinical trials of opioids for chronic pain","volume":"65","author":"Katz","year":"2005","journal-title":"Neurology"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fijcp.12807","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:09:37Z","timestamp":1643350177000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijcp.12807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,30]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"URL":"https:\/\/doi.org\/10.1111\/ijcp.12807","archive":["Portico"],"relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5,30]]}}}